Common familial influences on clustering of metabolic syndrome traits with central obesity and insulin resistance:: the Kiel obesity prevention study

被引:52
|
作者
Bosy-Westphal, A.
Onur, S.
Geisler, C.
Wolf, A.
Korth, O.
Pfeuffer, M.
Schrezenmeir, J.
Krawczak, M.
Mueller, M. J.
机构
[1] Univ Kiel, Agrar & Ernahrungswissenschfatfl Fak, Inst Humanernahrung & Lebensmittelkunde, D-24105 Kiel, Germany
[2] Univ Klinikum Schleswig Holstein, Int Med Informat & Stat, Kiel, Germany
[3] Bundesforschungsanstalt Ernahrung & Lebensmittel, Kiel, Germany
关键词
metabolic syndrome; insulin resistance; cross-trait heritability;
D O I
10.1038/sj.ijo.0803481
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The phenotypic heterogeneity of metabolic syndrome (MSX) suggests heterogeneity of the underlying genotype. The aim of the present study was to examine the common genetic background that contributes to the clustering between the two main features (insulin resistance, central obesity) and different MSX component traits. Methods: In all, 492 individuals from 90 families were investigated in a three-generation family path study as part of the Kiel Obesity Prevention Study (KOPS, 162 grandparents, 66.1 +/- 6.7 years, 173 parents, 41.3 +/- 5.4 years and 157 children, 10.8 +/- 3.4 years). Overall heritability was estimated and common familial (genetic and environmental) influences on insulin resistance (HOMA-IR) or central obesity (elevated waist circumference, WC), respectively, and different MSX traits were compared in a bivariate cross-trait correlation model. Results: Prevalence of MSX (according to NCEP criteria) was 27.2% (f) and 27.8% (m) in adults and 3.5% (f) and 8.5% (m) in children and adolescents, respectively. MSX phenotype was found to be highly variable, comprising 16 subtypes of component trait combinations. Within-trait heritability was 38.5% for HOMA-IR and 53.5% for WC, cross-trait heritability was 53.4%. As much as 6-18% and 3-10% of the shared variance between different MSX component traits (lipid profile, blood pressure) and WC or HOMA-IR, respectively, may be genetic. With the exception of HDL-C, the shared genetic variance between MSX component traits and WC was higher than the genetic variance shared with HOMA-IR. Conclusion: A common genetic background contributes to the clustering of different MSX component traits and central obesity or insulin resistance. Common genetic influences favour central obesity as a major characteristic linking these traits.
引用
收藏
页码:784 / 790
页数:7
相关论文
共 50 条
  • [41] Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance
    Yang, Kuen Cheh
    Hung, Hui-Fang
    Lu, Chia-Wen
    Chang, Hao-Hsiang
    Lee, Long-Teng
    Huang, Kuo-Chin
    SCIENTIFIC REPORTS, 2016, 6
  • [42] Visceral Hypercortisolism Observed in Central Obesity and Metabolic Syndrome Is Associated with Insulin Resistance and Beta Cell Dysfunction.
    Baudrand, R.
    Campino, C.
    Carvajal, C. A.
    Olivieri, O.
    Guidi, G.
    Faccini, G.
    Pasini, F.
    Sateler, J.
    Cornejo, J.
    San Martin, B.
    Dominguez, J. M.
    Tabilo, C.
    Mosso, L. M.
    Owen, G.
    Kalergis, A. M.
    Fardella, C.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [43] Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance
    Kuen Cheh Yang
    Hui-Fang Hung
    Chia-Wen Lu
    Hao-Hsiang Chang
    Long-Teng Lee
    Kuo-Chin Huang
    Scientific Reports, 6
  • [44] Insulin resistance and the metabolic syndrome are related to the severity of steatosis in the pediatric population with obesity
    Ubina-Aznar, Esther
    Tapia-Ceballos, Leopoldo
    Miguel Rosales-Zabal, Jose
    Porcel-Chacon, Rocio
    Poveda-Gomez, Francisco
    Lozano-Calero, Carmen
    Ortiz-Cuevas, Carmen
    Rivas-Ruiz, Francisco
    Sanchez-Cantos, Andres
    Maria Navarro-Jarabo, Jose
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2017, 109 (11) : 772 - 777
  • [45] Role of adipokines in obesity-linked insulin resistance, metabolic syndrome and atherosclerosis
    Kadowaki, T.
    Yamauchi, T.
    Kubota, N.
    Kamei, N.
    Tobe, K.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 164 - 164
  • [46] Copeptin as a Novel Biomarker of Obesity-Induced Insulin Resistance and Metabolic Syndrome
    Eltabakh, Soad M. M.
    Zeidan, Mohamed
    Maged, Hala
    Zikry, Magdy
    Khedr, Marwa
    DIABETES, 2018, 67
  • [47] Abdominal Obesity, Insulin Resistance, and the Metabolic Syndrome: Contribution of Physical Activity/Exercise
    Ross, Robert
    Despres, Jean-Pierre
    OBESITY, 2009, 17 : S1 - S2
  • [48] Obesity, insulin resistance, and the metabolic syndrome - Determinants of endothelial dysfunction in whites and blacks
    Lteif, AA
    Han, K
    Mather, KJ
    CIRCULATION, 2005, 112 (01) : 32 - 38
  • [49] Obesity, Central Adiposity and Clustering of Metabolic Syndrome Conditions in African and European American Women
    Brandon, L. Jerome
    Proctor, Larry
    Cole, Calvin L.
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2014, 46 (05): : 799 - 799
  • [50] Relationships among insulin resistance, obesity, diagnosis of the metabolic syndrome and cardio-metabolic risk
    Salazar, Martin R.
    Carbajal, Horacio A.
    Espeche, Walter G.
    Dulbecco, Carlos A.
    Aizpurua, Marcelo
    Marillet, Alberto G.
    Echeverria, Raul F.
    Reaven, Gerald M.
    DIABETES & VASCULAR DISEASE RESEARCH, 2011, 8 (02): : 109 - 116